SUBSCRIBE
SUBSCRIBE

Preclinical

Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Celgene CEO: Partnerships Bear Fruit to Four New Compounds
May 11, 2015
 · 
3 min read
EXCLUSIVE: Navidea CEO Tells BioSpace New Cancer Treatment Will See More Trial Data in 2015
Drug Development
EXCLUSIVE: Navidea CEO Tells BioSpace New Cancer Treatment Will See More Trial Data in 2015
April 28, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Bayer HealthCare Strikes Deal With Mission Bay Incubator Tenant Aronora
February 24, 2015
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Despite CEO’s Comments, Experimental Sarepta Drug Protects Lab Monkeys From Ebola
February 11, 2015
 · 
5 min read
BIOCEO15 ContraFect CEO Says Lysin, AB Anti-Infectives Are “Game-Changers” in 2015
Drug Development
BIOCEO15: ContraFect CEO Says Lysin, AB Anti-Infectives Are “Game-Changers” in 2015
February 9, 2015
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Two of Roche’s Experimental Parkinson’s Drugs Caused Lung Toxicity in Monkeys
February 6, 2015
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Novartis AG Researchers Claim to Have Discovered “Fountain of Youth” Drug
December 29, 2014
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
AstraZeneca PLC To Test Whether It Can Undo Effects Of Its Own Heart Drug Brilinta
November 13, 2014
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Omeros Corporation Suspends Enrollment In Huntington’s Disease Trial; Stock Down 11.36% At 8:40AM ET On Tuesday
October 21, 2014
 · 
2 min read
Ebola Clinical Trials: Big Name Players In The Ebola Race
BioCapital
Ebola Clinical Trials: Big Name Players In The Ebola Race
October 20, 2014
 · 
12 min read
Load More
PRESS RELEASES
Press Releases
Vividion Publishes Discovery of First-in-Class KEAP1 Activator, Supporting Ongoing Clinical Program in Oncology
December 23, 2025
 · 
3 min read
Press Releases
Mondego Bio Announces Selection of a PTPN2 Inhibitor Clinical Candidate and Targets First-in-Human Trials in H1 2026
December 22, 2025
 · 
3 min read
Press Releases
Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
December 18, 2025
 · 
14 min read
Press Releases
Singlera Genomics announces research collaboration with the University of Pittsburgh to advance pancreatic cancer early detection
December 18, 2025
 · 
2 min read
Press Releases
Zelluna Reaches Major Milestone and Submits Clinical Trial Application in the UK for First-in-Human Study of ZI-MA4-1 (ZIMA-101), the World’s First MAGE-A4-Targeting TCR-NK Cell Therapy for Solid Tumours
December 18, 2025
 · 
4 min read
Press Releases
Zelluna Publishes Compelling Preclinical Data for ZI-MA4-1, the World’s First MAGE-A4-Targeting TCR-NK Therapy for Solid Tumours
December 16, 2025
 · 
4 min read
Press Releases
Feinstein Institutes’ Researchers Develop Promising Therapeutic for Sepsis-Induced Acute Lung Injury
December 16, 2025
 · 
4 min read
Press Releases
IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications
December 16, 2025
 · 
6 min read
Press Releases
Atelerix Enters Agreement with Cherry Biotech to Integrate Non-cryogenic Transport Solutions With Advanced Organoid Models
December 15, 2025
 · 
2 min read
Press Releases
LIR Life Sciences Files Provisional Patent Application for Needle-Free Delivery of GLP/GIP-Based Obesity Therapies
December 12, 2025
 · 
5 min read
Press Releases
Io Therapeutics, Inc., presents today at the San Antonio Breast Cancer Symposium preclinical studies demonstrating effectiveness of IRX4204, the company’s clinical stage retinoid X nuclear receptor (RXR) agonist compound, for synergistically promoting killing of HER2+ breast cancer cells in combination with HER2-targeted chimeric antigen receptor modified T-cells (CAR-T).
December 12, 2025
 · 
3 min read
Press Releases
NiKang Therapeutics Presents Discovery of NKT5097, a First-in-Class, Highly Potent and Selective, Orally Bioavailable CDK2/4 Dual Degrader for Cancer Therapy at SABCS 2025
December 12, 2025
 · 
3 min read
Press Releases
Polyrizon Announces Promising Permeation Kinetics Supporting Advancement of Its Intranasal Naloxone Hydrogel Program
December 12, 2025
 · 
6 min read
Press Releases
Lexicon Pharmaceuticals Announces Publication of Preclinical Data in the Journal of the Endocrine Society on Acyl-CoA Synthetase 5 (ACSL5) Reinforcing the Scientific Rationale for LX9851
December 11, 2025
 · 
5 min read
Press Releases
MED Institute and Sus Clinicals Announce Strategic Collaboration to Advance Preclinical Testing for Medical Product Innovation
December 11, 2025
 · 
2 min read
Press Releases
BBOT Announces Late-Breaking Preclinical Data on BBO-10203, a First-in-Class RAS:PI3Kα Breaker, at the San Antonio Breast Cancer Symposium (SABCS)
December 11, 2025
 · 
7 min read
Press Releases
IDEAYA Biosciences Announces IND Submission for IDE574, a Potential First-In-Class KAT6/7 Dual Inhibitor for Breast and Lung Cancers
December 10, 2025
 · 
4 min read
Press Releases
Innovent Announces First Participant Dosed in a Phase 1 Clinical Trial of IBI3011, a Recombinant Anti-Human Interleukin 1 Receptor Accessory Protein Monoclonal Antibody
December 10, 2025
 · 
7 min read
Press Releases
Akari Therapeutics Highlights Preclinical Data Demonstrating Therapeutic Potential of Lead Candidate, AKTX-101, for Hard-to-Treat K-Ras Mutant Pancreatic Cancer
December 10, 2025
 · 
8 min read
Press Releases
BenchSci Extends ASCEND Agreement with Merck to Support Preclinical Disease Biology Research
December 10, 2025
 · 
2 min read
Load More